MENU
MLTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

MoonLake Immunotherapeutics (MLTX) Earnings Date & Reports

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases... Show more

A.I. Advisor
published Earnings

MLTX is expected to report earnings to fall 18.85% to -89 cents per share on February 26

MoonLake Immunotherapeutics MLTX Stock Earnings Reports
Q4'25
Est.
$-0.89
Q3'25
Missed
by $0.22
Q2'25
Missed
by $0.15
Q1'25
Beat
by $0.13
Q4'24
Missed
by $0.12
The last earnings report on November 05 showed earnings per share of -110 cents, missing the estimate of -87 cents. With 2.38M shares outstanding, the current market capitalization sits at 889.84M.
View a ticker or compare two or three
MLTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MLTX showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Dorfstrasse 29
Phone
+41 415108022
Employees
50
Web
https://www.moonlaketx.com